Agrypnia and Gastrointestinal inflammation

Summary:

Gastrointestinal inflammation is found among people with Agrypnia, especially for people who are female, 60+ old.

The study analyzes which people have Gastrointestinal inflammation with Agrypnia. It is created by eHealthMe based on reports of 77 people who have Agrypnia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 30, 2022

77 people who have Agrypnia and Gastrointestinal Inflammation are studied.


What is Agrypnia?

Agrypnia is found to be associated with 4,476 drugs and 4,951 conditions by eHealthMe.

What is Gastrointestinal inflammation?

Gastrointestinal inflammation (inflammation of stomach and intestine) is found to be associated with 759 drugs and 492 conditions by eHealthMe.

Number of Gastrointestinal inflammation in Agrypnia reports submitted per year:

Would you have Gastrointestinal inflammation when you have Agrypnia?

Gender of people who have Agrypnia and experienced Gastrointestinal Inflammation *:

  • female: 75 %
  • male: 25 %

Age of people who have Agrypnia and experienced Gastrointestinal Inflammation *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 8.93 %
  • 30-39: 19.64 %
  • 40-49: 19.64 %
  • 50-59: 10.71 %
  • 60+: 41.07 %

Common co-existing conditions for these people *:

  1. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 40 people, 51.95%
  2. Stress And Anxiety: 29 people, 37.66%
  3. High Blood Pressure: 24 people, 31.17%
  4. Nausea (feeling of having an urge to vomit): 18 people, 23.38%
  5. Depression: 16 people, 20.78%
  6. Constipation: 16 people, 20.78%
  7. Pain: 15 people, 19.48%
  8. High Blood Cholesterol: 14 people, 18.18%
  9. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 13 people, 16.88%
  10. Colitis (inflammation of colon): 9 people, 11.69%

Common drugs taken by these people *:

  1. Humira: 43 people, 55.84%
  2. Pantoprazole: 16 people, 20.78%
  3. Vitamin D: 10 people, 12.99%
  4. Escitalopram: 9 people, 11.69%
  5. Nexium: 9 people, 11.69%
  6. Ambien: 8 people, 10.39%
  7. Decadron: 7 people, 9.09%
  8. Zyprexa: 7 people, 9.09%
  9. Emend: 7 people, 9.09%
  10. Aloxi: 7 people, 9.09%

Common symptoms for these people *:

  1. Abdominal Pain: 26 people, 33.77%
  2. Diarrhea: 22 people, 28.57%
  3. Nausea And Vomiting: 21 people, 27.27%
  4. Nausea (feeling of having an urge to vomit): 19 people, 24.68%
  5. Fatigue (feeling of tiredness): 14 people, 18.18%
  6. Drug Ineffective: 13 people, 16.88%
  7. Weight Increased: 13 people, 16.88%
  8. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 13 people, 16.88%
  9. Malaise (a feeling of general discomfort or uneasiness): 12 people, 15.58%
  10. Intestinal Obstruction: 10 people, 12.99%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Gastrointestinal inflammation?

Check whether Gastrointestinal inflammation is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Gastrointestinal inflammation:

Common drugs associated with Gastrointestinal inflammation:

All the drugs that are associated with Gastrointestinal inflammation:

Common conditions associated with Gastrointestinal inflammation:

All the conditions that are associated with Gastrointestinal inflammation:

How the study uses the data?

The study is based on Gastrointestinal inflammation and Agrypnia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: